#United States #New York #NYU Langone #ophthalmology #Dr. Skondra

NYU Langone's New Vision in Ophthalmology

In a significant move for ophthalmology, NYU Grossman School of Medicine has appointed Dr. Dimitra Skondra, MD, PhD, as the Vice Chair of Research in its Department of Ophthalmology. With more than twenty years of distinguished experience, Dr. Skondra's expertise in retinal health, coupled with her pioneering research on the gut microbiome's influence, positions her to bring an innovative outlook to patient care and medical research.

Background and Expertise

Dr. Skondra joins NYU Langone Health from the University of Chicago, where she not only served as a professor of ophthalmology but also directed the J. Terry Ernest Ocular Imaging Center and the Microbiome Medicine Program. Her medical journey commenced at the University of Crete Medical School in Greece, where she graduated summa cum laude, followed by specialized training at Cornell University and a vitreoretinal surgery fellowship at Harvard Medical School.

Her research sheds light on vital systemic influences on ocular health, notably how diet and the gut microbiome affect conditions like age-related macular degeneration (AMD). Dr. Skondra has identified causal links between gut dysbiosis and retinal diseases, propelling the development of new preventive and therapeutic strategies for patients.

Commitment to Innovation

The appointment of Dr. Skondra is seen as a testament to NYU Langone's dedication to pioneering research and patient-centered medicine. Kathryn A. Colby, MD, PhD, Chair of the Department of Ophthalmology, remarked on Dr. Skondra’s invaluable role as a clinician-scientist whose focus on innovative practices aligns seamlessly with the institution’s mission.

In her new position, Dr. Skondra aims to leverage international expertise in ocular diseases like AMD, integrating her research with clinical practices to develop personalized medicine frameworks. She expresses enthusiasm about the possibilities for advancing eye health and patient treatment with a proactive model aimed at disease prevention.

Expanding Research Horizons

Building on her groundwork in the gut microbiome, Dr. Skondra plans to broaden her research scope to include other ocular conditions such as glaucoma and corneal diseases. She will spearhead initiatives to leverage multiomics data alongside artificial intelligence analytics, developing tailored treatment plans that focus on prediction and prevention rather than mere reaction.

Collaboration will be key in her research approach – she seeks to partner with experts across varying specialties, including neurology and cardiology, to utilize advanced retinal imaging and vascular assessments as noninvasive early indicators of neurological and cardiovascular issues. This cross-disciplinary collaboration positions NYU Langone at the forefront of retinal disease research and precision medicine innovation.

Clinical Practice and Surgical Contributions

Beyond her research ambitions, Dr. Skondra will actively engage in clinical practice concentrating on complex retinal disorders. She is recognized nationally for her expertise in managing complicated retinal detachment cases and has innovated noninvasive treatment methods for macular holes that boast up to a 70% success rate in preventing surgical intervention.

Dr. Skondra has also gained recognition for her work repurposing existing medications, such as metformin, to slow the progression of AMD. Her upcoming clinical trial, in collaboration with the University of California, San Francisco, aims to implement this strategy within early-stage AMD populations, highlighting her commitment to making effective treatments accessible.

Conclusion

Dr. Dimitra Skondra's appointment as Vice Chair of Research marks a significant leap forward for the NYU Grossman School of Medicine’s Department of Ophthalmology. Her significant past achievements, combined with her visionary plans, promise to usher in a new era of research and treatment methodologies that prioritize patient care and innovative ophthalmic science. As the field of ophthalmology continues to evolve, Dr. Skondra stands at the forefront of this critical transition, ready to shape the future of retinal health and precision medicine.